Drug Database
Back to search

Netherlands· NL-696ade3d2ed2

Arlevert 20 mg/40 mg tabletten

A cinnarizin, kombinationen product containing cinnarizine + dimenhydrinaat, registered in Netherlands by Hennig Arzneimittel GmbH & Co. KG. The same ATC class is registered in 9 of our 19 countries.

ATC N07CA52

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedArlevert 20 mg/40 mg tablettenATCN07CA52REGISTER NO.NL-696ade3d2ed2PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cinnarizine + dimenhydrinaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cinnarizin, kombinationen is registered in 9 of 19 countries.

Countries holding a registration under ATC N07CA52 (cinnarizin, kombinationen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search cinnarizin, kombinationen products by name

Cinnarizin, kombinationen · ATC N07CA52

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cinnarizin, kombinationen costs, country by country.

Normalised to the WHO defined daily dose (90 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Cinnarizin, kombinationen · price per daily dose (90 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.98
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CINNARIZINE + DIMENHYDRINAAT
Manufacturer
Hennig Arzneimittel GmbH & Co. KG
Country
Netherlands (NL)
ATC code
N07CA52
ATC class
Cinnarizin, Kombinationen
Defined daily dose
90 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    34875

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cinnarizin, kombinationen in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cinnarizin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Arlevert
  • Belgium · Arlevertan
  • Bulgaria · Азалонум, Арлеверт
  • Cyprus · Arlevert, Azalonum
  • Czechia · Arlevert, Medovert
  • Germany · Arlevert, Cinna/Dimen
  • Denmark · Arlevert
  • Estonia · Arlevert, Azalonum
  • Spain · Dizinel
  • Finland · Arlevert
  • United Kingdom (Northern Ireland) · Arlevert, Cinnarizine/Dimenhydrinate Brown & Burk Uk
  • Greece · Arlevert, Azalonum
  • Croatia · Azalonum
  • Hungary · Arlevert
  • Ireland · Arlevert
  • Italy · Agivert, Arlevertan
  • Lithuania · Arlevert, Azalonum
  • Luxembourg · Arlevertan, Cinnarizin/Dimenhydrinat Micro Labs
  • Latvia · Arlevert, Azalonum
  • Malta · Azalonum
  • Poland · Aludran, Arlevert
  • Portugal · Arlevert, Cinarizina + Dimenidrinato Biofarmoz
  • Romania · Arlevert, Azalonum
  • Sweden · Arlevert, Azalonum
  • Slovenia · Arlevert
  • Slovakia · Arlevert, Medovert

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d586f620-aea3-46b1-9872-c8a220a56532
GET /v1/drugs/d586f620-aea3-46b1-9872-c8a220a56532?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h34875_smpc.pdf",
  "strength": null,
  "atc_label": "Cinnarizine, Combinations",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg34875",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE (E 464)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)"
  ],
  "substances": [
    "CINNARIZINE",
    "DIMENHYDRINAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h34875.pdf",
  "authorised_at": "2008/04/02",
  "procedure_number": "AT/H/0500/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "34875",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about cinnarizin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console